Noncytotoxic and Sublethal Paclitaxel Treatment Potentiates the Sensitivity of Cultured Ovarian Tumor SKOV-3 Cells to Lysis by Lymphokine-activated Killer Cells
碩士 === 長庚大學 === 臨床醫學研究所 === 95 === The standard treatment of advanced epithelial ovarian cancer is tumor debulking by surgery, followed by six cycles of chemotherapy consisting of cisplatinum and paclitaxel. However, this therapy protocol is not satisfactory, since about 50% of the treated patients...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2007
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/24703372721905313876 |